A Randomized Controlled Clinical Trial on Exocarpium Citri Grandis Phlegm Cough Solution Alleviating the Symptoms of Community-Acquired Pneumonia (CAP) in Adults

Maoming People's Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients aged 18 to 80 years;
•2. Those patients diagnosed with community-acquired pneumonia according to the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of community-acquired pneumonia for adults 2018;
•3. Patients with cough, expectoration or asthma;
•4. Patients who can take medicine orally;
•5. The patient or his legal representative voluntarily participated in the study and signed the informed consent.

•1. Patients with pregnant or lactating women;
•2. Patients who had allergic reaction to Juhong expectoration liquid in the past;
•3. Patients who can't cooperate with BCSS score and VAS score (such as disturbance of consciousness, mental retardation, etc.);
•4. Patients with severe systemic diseases (such as malignant tumor, autoimmune disease, liver or kidney disease) or surgery (organ transplantation, splenectomy);
•5. Patients who are participating in clinical trials of other drugs;
•6. Any other situation that the researcher thinks is not suitable to participate in the clinical trial (such as increasing the risk of the subject or interfering with the judgment of the end point of the study, etc.).

发起方